Cite
The cancer glycocode as a family of diagnostic biomarkers, exemplified by tumor-associated gangliosides.
MLA
Nejatie, Ali, et al. “The Cancer Glycocode as a Family of Diagnostic Biomarkers, Exemplified by Tumor-Associated Gangliosides.” Frontiers in Oncology, vol. 13, Oct. 2023, p. 1261090. EBSCOhost, https://doi.org/10.3389/fonc.2023.1261090.
APA
Nejatie, A., Yee, S. S., Jeter, A., & Saragovi, H. U. (2023). The cancer glycocode as a family of diagnostic biomarkers, exemplified by tumor-associated gangliosides. Frontiers in Oncology, 13, 1261090. https://doi.org/10.3389/fonc.2023.1261090
Chicago
Nejatie, Ali, Samantha S Yee, Anna Jeter, and Horacio Uri Saragovi. 2023. “The Cancer Glycocode as a Family of Diagnostic Biomarkers, Exemplified by Tumor-Associated Gangliosides.” Frontiers in Oncology 13 (October): 1261090. doi:10.3389/fonc.2023.1261090.